BOX7–3 MUSCULAR DYSTROPHY
Muscular dystrophyis really a group of genetic
diseases in which muscle tissue is replaced by
fibrous connective tissue or by fat. Neither of these
tissues is capable of contraction, and the result is
progressive loss of muscle function. The most com-
mon form is Duchenne’s muscular dystrophy, in
which the loss of muscle function affects not only
skeletal muscle but also cardiac muscle. Death usu-
ally occurs before the age of 20 due to heart failure,
and at present there is no cure.
Duchenne’s muscular dystrophyis a sex-
linked(or X-linked) trait, which means that the
gene for it is on the X chromosome and is recessive.
The female sex chromosomes are XX. If one X chro-
mosome has a gene for muscular dystrophy, and
the other X chromosome has a dominant gene for
normal muscle function, the woman will not have
muscular dystrophy but will be a carrier who may
pass the muscular dystrophy gene to her children.
The male sex chromosomes are XY, and the Y has
no gene at all for muscle function, that is, no gene
to prevent the expression of the gene on the X
chromosome. If the X chromosome has a gene for
muscular dystrophy, the male will have the disease.
This is why Duchenne’s muscular dystrophy is more
common in males; the presence of only one gene
means the disease will be present.
The muscular dystrophy gene on the X chromo-
some has been located, and the protein the gene
codes for has been named dystrophin. Dystrophin is
necessary for the stability of the sarcolemma and
the proper movement of ions. Treatments for mus-
cular dystrophy that are being investigated include
the injection of normal muscle cells or stem cells
into affected muscles, and the insertion (using
viruses) of normal genes for dystrophin into
affected muscle cells.
Increased muscle
contraction
Increased cell
respiration
Increased ATP
production
Increased need
for O 2
Increased CO 2
production
Increased heat
production
Increased
sweating
Increased respiration
Increased heart rate
Vasodilation in muscles
Figure 7–6. Responses of the
body during exercise.
QUESTION:Name all the organ
systems depicted here.
BOX7–4 MYASTHENIA GRAVIS
which acetylcholine bonds and stimulates the entry
of Naions. Without these receptors, the acetyl-
choline released by the axon terminal cannot cause
depolarization of a muscle fiber.
Treatment of myasthenia gravis may involve
anticholinesterase medications. Recall that cholin-
esterase is present in the sarcolemma to inactivate
acetylcholine and prevent continuous, unwanted
impulses. If this action of cholinesterase is inhibited,
acetylcholine remains on the sarcolemma for a
longer time and may bond to any remaining recep-
tors to stimulate depolarization and contraction.
Myasthenia gravisis an autoimmune disorder
characterized by extreme muscle fatigue even after
minimal exertion. Women are affected more often
than are men, and symptoms usually begin in middle
age. Weakness may first be noticed in the facial or
swallowing muscles and may progress to other mus-
cles. Without treatment, the respiratory muscles will
eventually be affected, and respiratory failure is the
cause of death.
In myasthenia gravis, the autoantibodies (self-
antibodies) destroy the acetylcholine receptors
on the sarcolemma. These receptors are the sites to
148